Search

Author/Creator Lin, Kevin K

1. 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246). (27th October 2022)

Authors:
Oaknin, Ana; Kristeleit, Rebecca S; Mahdi, Haider S; Lim, Myong Cheol; de Vivo, Rocco; Salinas, Erin A; Wilson, Michelle K; Liontos, Michalis; Santin, Alessandro D; Provencher, Diane M; Demirkiran, Fuat; Willmott, Lyndsay J; Chudecka-Głaz, Anita M; Herzog, Thomas J; Beiner, Mario E; Copeland, Lar...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A472
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Issue 1 (January 2017)

Authors:
Swisher, Elizabeth M; Lin, Kevin K; Oza, Amit M; Scott, Clare L; Giordano, Heidi; Sun, James; Konecny, Gottfried E; Coleman, Robert L; Tinker, Anna V; O'Malley, David M; Kristeleit, Rebecca S; Ma, Ling; Bell-McGuinn, Katherine M; Brenton, James D; Cragun, Janiel M; Oaknin, Ana; Ray-Coquard, Isabe...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Issue 1 (January 2017)

Authors:
Swisher, Elizabeth M; Lin, Kevin K; Oza, Amit M; Scott, Clare L; Giordano, Heidi; Sun, James; Konecny, Gottfried E; Coleman, Robert L; Tinker, Anna V; O'Malley, David M; Kristeleit, Rebecca S; Ma, Ling; Bell-McGuinn, Katherine M; Brenton, James D; Cragun, Janiel M; Oaknin, Ana; Ray-Coquard, Isabe...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10106 (28th October 2017)

Authors:
Coleman, Robert L; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstron...
Journal:
Lancet
Issue:
Volume 390:Issue 10106(2017)
Page Start:
1949
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial. Issue 4 (April 2022)

Authors:
Kristeleit, Rebecca; Lisyanskaya, Alla; Fedenko, Alexander; Dvorkin, Mikhail; de Melo, Andreia Cristina; Shparyk, Yaroslav; Rakhmatullina, Irina; Bondarenko, Igor; Colombo, Nicoletta; Svintsitskiy, Valentyn; Biela, Luciano; Nechaeva, Marina; Lorusso, Domenica; Scambia, Giovanni; Cibula, David; Pó...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 4(2022)
Page Start:
465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗